Before incorporation, ViveSpoon was selected to participate in Phase 1 of the JETRO J-StarX Medtech course.
JETRO announced 15 participants on 30 September 2025. The pre-incorporation venture appears in the public announcement as “ViveSpoon NewCo.”
The programme provided a framework for examining healthcare, research, and commercial environments overseas and the issues relevant to future international development. Selection for the programme did not indicate product approval or availability in any overseas market.